Immunome IMNM
NASDAQ IMNM
$17.92 +1.15 (+6.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Immunome (IMNM) FCF Margin (2020 - 2025)

Updated

Immunome's FCF Margin was -2890.13% in FY2025, down 1585.33 percentage points from -1304.80% in FY2024.

Analysis

Immunome (IMNM) FCF Margin (2020 - 2025) Analysis & Trends

  • Per Business Quant data, FCF Margin in earlier years was -1304.80% in FY2024 (-1244.88 pp) and -59.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 28.82%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 18.33%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 6.55%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 44.00%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 2.01%
10 Immunome 2.04 Bn 6.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,252.95%
Mar 31, 2025 -1,938.48%
Dec 31, 2024 -1,577.28%
Sep 30, 2024 -1,227.01%
Jun 30, 2024 -1,088.87%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -140.93%
Mar 31, 2023 1,018.06%
Dec 31, 2022 -675,500.00%
Sep 30, 2022 -757,100.00%
Jun 30, 2022 -411,500.00%
Mar 31, 2022 -638,200.00%
Jun 30, 2020 -36,820.00%
API Access

Immunome FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY